Yaltormin SR is a pharmaceutical medication primarily used in the management and treatment of type 2 diabetes mellitus. It belongs to a class of drugs known as biguanides, with its active ingredient being metformin hydrochloride. Yaltormin SR is formulated as a sustained-release (SR) tablet, designed to slowly release the medication into the body over an extended period, which helps in maintaining more stable blood glucose levels throughout the day. This mode of action not only aids in controlling blood sugar levels but also minimizes the risk of side effects commonly associated with rapid medication release. It works by improving the sensitivity of body tissues to insulin, thereby facilitating more effective glucose uptake and utilization, and reducing glucose production in the liver. Yaltormin SR is often prescribed as part of a comprehensive treatment plan that includes diet, exercise, and regular blood sugar monitoring.